ENTITY
Hangzhou Tigermed Consulting (A)

Hangzhou Tigermed Consulting (A) (300347 CH)

126
Analysis
Health Care • China
Hangzhou Tigermed Consulting Company Limited provides professional clinical research services for domestic and foreign pharmaceutical and health-related research and development. The Company's main services include clinical trial technology services, data management, and statistical analysis.
more
bullish•Frontage Holdings
•30 May 2019 01:07

Frontage Holdings IPO: Bull/​​Bear Case DCF Scenarios

Frontage Holdings (1521 HK) is a global contract research organisation (CRO) which is backed byĀ Hangzhou Tigermed Consulting (300347 CH)....

Logo
767 Views
Share
bullish•Frontage Holdings
•15 May 2019 18:23

Frontage Holdings IPO: Risk-Reward Is Favourable at the Low-End of Price Range

Frontage Holdings (1521 HK)Ā has launched its Hong Kong IPO at a price range of HK$2.55-3.20 per share to raise HK$1.27-1.60 billion ($160-200...

Logo
864 Views
Share
bullish•Frontage Holdings
•15 May 2019 15:03

Frontage Holdings (ę–¹č¾¾ęŽ§č‚”) IPO:Ā Reasonable Valuation & Quality Cornerstones

Frontage Holdings,Ā a pre-clinical CRO arm of A-share listed Hangzhou Tigermed Consulting (300347 CH),Ā started book building today to raise up to...

Logo
931 Views
Share
bearish•Frontage Holdings
•08 May 2019 15:36

Frontage Holdings IPO Preview: An Uncertain Transition

Frontage Laboratories Inc (1000371Z HK) is a global contract research organisation (CRO) which is backed by Hangzhou Tigermed Consulting (300347...

Logo
765 Views
Share
bullish•Frontage Holdings
•20 Mar 2019 16:23

Frontage Holding (ę–¹č¾¾ęŽ§č‚”) IPO:Ā Updates from 2018 Numbers

Frontage Holding, a contract research organization subsidiary of A-share listedĀ Hangzhou Tigermed Consulting (300347 CH), re-filed to list on the...

Logo
921 Views
Share
x